Home » ICH Guidance Urges Use of Risk Assessments for CQAs
ICH Guidance Urges Use of Risk Assessments for CQAs
July 11, 2011
Drugmakers should use risk assessments to identify material attributes and manufacturing process parameters that may affect a drug’s critical quality attributes (CQAs), a draft International Conference on Harmonisation (ICH) guidance says.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
21Oct